The landscape is also shaped by manufacturing capacity concerns: At last weeks Semafor World Economy, Eli Lillys CEO framed new oral pills as a huge scale solution for global supply constraints, saying that no matter how hard we want to try, we cannot reach the planet with traditional injectable treatments.
For comparison, in the same period, Ozempic sales were up 1% to around $5 billion, and Wegovy grew 17% to $3.44 billion but both shrank by around 2% in the US market
Unlike morning dosing, which gets built into the start-of-day routine, evening dosing competes with relaxation, family time, and simple exhaustion
3mo ago On Apr 9, 2026 Khursheda N
Here's what you need to know about Medicare's new GLP-1 Bridge program: fox59.com/news/national-